ANEBULO PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -141.3% | -141.3% | -139.7% |
| FY2022 | -45.3% | -45.3% | -43.8% |
| FY2023 | -110.7% | -110.7% | -100.5% |
| FY2024 | -215.1% | -215.1% | -201.4% |
| FY2025 | -72.8% | -72.8% | -69.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -141.3% | -141.3% | -139.7% |
| FY2022 | -45.3% | -45.3% | -43.8% |
| FY2023 | -110.7% | -110.7% | -100.5% |
| FY2024 | -215.1% | -215.1% | -201.4% |
| FY2025 | -72.8% | -72.8% | -69.9% |